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Abstract   
An increase in the frequency of blood donation among the donor population is liable to result 
in excessive iron loss and development of iron deficiency anemia. In the majority of blood 
banks, hemoglobin and/or hematocrit measurements are used as screening tests for the ability 
to donate blood even though iron stores may be depleted in donors with hemoglobin values 
above the arbitrarily defined limit for anemia. In the present study, we have reviewed the iron 
deficiency in blood donors and characteristics which predispose to this condition. 
Keywords: Blood donors, Iron stores
Introduction  
The occurrence of iron depletion and 
deficiency in first-time and repeat blood 
donors is well-documented in the 
transfusion medicine literature (1-3). With 
each whole blood (WB) donation, male 
donors lose 242 ±17 mg and female donors 
lose 217 ±11 mg of iron (1). Given that 
normal iron stores in men and women are 
1000 mg and 350 mg, respectively, 
maintenance of iron balance is a challenge 
in the blood donors. Iron deficiency is a 
significant cause of deferral. If iron is not 
replaced, donors may become iron 
deficient. All blood donors are screened at 
each visit for hemoglobin (Hb) levels. 
Even among blood donors who have 
normal Hb values, iron deficiency is 
prevalent (4). Therefore, Hb levels alone 
are inadequate for distinguishing blood 
donors with iron deficiency without 
anemia (5). Moreover, some deferred 
blood donors do not return to donate, 
especially first-time donors. While there is 
a steady push for recruitment of more 
regular donors and encouragement of first 
time donors to give blood regularly in 
order to increase the safety of national 
blood supplies(6). Blood banks have the 
responsibility to prevent anemia among 
donors. In the present study, we have 
reviewed the iron deficiency in blood 
donors and characteristics which 
predispose to this condition. 
Diagnostic tests of iron deficiency in 
blood donors: In the majority of blood 
banks, Hb has generally been used as a 
screening test for the suitability to give 
blood. However, it has been reported that 
this parameter has poor sensitivity, 
especially in the detection of early stages 
of iron deficiency. Indeed, an accurate 
diagnosis of iron deficiency requires 
several laboratory tests. Measurements of 
serum iron, serum ferritin concentrations, 
mean cell volume (MCV) and mean 
corpuscular hemoglobin (MCH) can be 
used with a high degree of accuracy and 
precision(7, 8). In the study by Simon et 
al, using ferritin ≤ 12 ng/ml to define iron 
depletion the overall frequency in regular 
blood donors was 8% in males and 23% in 
females(9).  A systematic review found 
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ferritin levels to be superior to several 
other tests (MCV, %Sat, zinc 
protoporphyrin), and ferritin < 15 ng/mL 
confirms the diagnosis of iron deficiency 
(10). Other studies suggest higher levels 
(22-40 µg/L) more sensitively reflect iron-
deficient erythropoiesis (10-12). As in 
clinical studies, it is obvious that a ferritin 
cutoff of 12 ng/mL is a specific marker of 
iron depletion in blood donors, but also 
lacks sensitivity (13). One study found that 
this cutoff failed to identify iron depletion 
in over 1/3 of cases in blood donors (14). 
The investigators found a higher ferritin 
level, 22 ng/mL, more indicative of 
functional iron depletion. These 
investigations were not based on the “gold 
standard” bone marrow iron stains or a 
hematologic response to iron, but relied 
(9). In order to find out the usefulness of 
serum iron and ferritin for correct 
diagnosis of iron deficiency in hospitalized 
patients, Burns et al (15) compared the 
results of serum iron and ferritin tests with 
the presence of stainable iron in bone 
marrow aspirates from 301 patients. Iron 
deficiency was correctly detected by serum 
iron in only 41% and ferritin in 90% of 
patients, respectively. These investigators 
concluded that iron measurements, not 
have the adequate sensitivity and/or 
specificity for precise diagnosis of iron 
deficiency. 
Iron stores in regular and first-time 
blood donors: In Adediran et al (16) 
study, the mean serum ferritin level was 
significantly lower in the regular donors 
than in the first time donors. Szymczyk-
Nuzka et al (17) when determining the 
prevalence of iron deficiency in regular 
blood donors noted a lower serum ferritin 
in this group in contrast with first-time 
donors who had normal serum ferritin 
levels. Norashikin et al (18) also reported 
significantly lower serum ferritin levels in 
regular blood donor. Several investigators 
have noted a significant reduction in 
ferritin levels with increasing donations 
(18-21). However, Vilzu et al (22) 
reported no significant difference between 
ferritin levels in controls and donors 
donating less than 20 units.  Akpotuzor et 
al (23) reported that there was no 
observable difference in biochemical iron 
parameters between regular donors and 
normal controls. In contrast, several other 
studies have documented lower serum iron 
levels in regular blood donors compared 
with healthy controls (19). 
The effect of repeated blood donations on 
the iron status of male and female blood 
donors 
The results of a study on the iron status of 
male Saudi blood donors showed that 
increased number of donations result in 
iron deficiency anemia, although the level 
of hemoglobin remained acceptable for 
blood donation(24). Results of a study in 
Iran (25) showed that 11% of male regular 
donors and 0.8% of first-time donors had 
iron store depletion. Among blood donors, 
premenopausal women are at high risk of 
iron deficiency, (26) and preventing and 
alleviating this problem is a major concern 
for blood services (27). Postmenopausal 
women can donate blood without 
becoming iron deficient if they have 
initially had adequate iron stores (28). 
However, women of childbearing age are 
at increased risk of iron deficiency if they 
donate blood more than one unit a year 
(29). Cable et al (30) study showed that 
absent iron stores (AIS), and iron deficient 
erythropoiesis (IDE), are highly prevalent 
in frequent blood donors. They defined 
AIS as a ferritin level below 12 ng/mL and 
IDE as present if the log of the ratio of 
soluble transferrin receptor to ferritin was 
greater than or equal to 2.07. In regular 
male donors, 16.4% had AIS and 48.7% 
IDE, while 27.1% and 66.1% of female 
regular donors have AIS and IDE, 
respectively.  In a study by Yousefinejad 
et al (31) the donors with more than five 
instances of donation have considerably 
lower serum ferritin than ones with five 
instances of donation and less, comparing 
with the results of two previous studies 
performed in Iran (32, 33), while a study 
in Pakistan mentioned the relationship 
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between four and more instances of 
donation in the past two years and iron 
deficiency (34). Therefore, it seems 
primary evaluations before blood donation 
is necessary for regular male donors from 
the fifth donation onwards with not just 
attention to Hb level; usage of iron 
supplements in this group should be 
evaluated and this matter had been 
emphasized in previous studies as well(32, 
34). A study by Mirrezaie et al, (35) 
indicated that replacing the iron lost at 
donation can protect the female regular 
donors from iron deficiency, and assist in 
retaining this group of donors for future 
donation. 
Predictors of iron levels in blood 
donors: Rigas et al. (36) published a paper 
in which they described predictors of iron 
levels in 14,737 Danish blood donors. 
Among high-frequency donors (more than 
nine donations in the past 3 years), they 
found iron deficiency (ferritin below 15 
ng/ml) in 9, 39, and 22% of men, 
premenopausal women, and 
postmenopausal women, respectively. The 
strongest predictors of iron deficiency 
were gender, the number of blood 
donations in a 3-year period, menopausal 
status, and the time since previous 
donation. Other major factors included 
age, weight, and intensity of menstruation, 
iron tablets and vitamin pills. Cable et al, 
(30) found that donation frequency is the 
strongest predictor for iron stores. 
Furthermore, they report that gender, 
weight, iron supplements, dairy products, 
and age for women are significantly 
associated with AIS. They also reported 
that age in men, smoking, menstruation 
status, giving birth, and beef are associated 
with IDE. Furthermore, smoking and time 
since last donation are correlated with a 
lower risk of AIS (3).  Both pica and 
restless legs syndrome (RLS) have been 
reported to occur in blood donors (37-39). 
Serum ferritin levels below 45–50 mcg/L 
have been found to exacerbate restless legs 
syndrome (RLS) (40, 41). In a study by 
Bryant et al,(42) the presence of pica and 
restless legs syndrome (RLS) was 
prospectively assessed in blood donors. 
Pica was reported in 11% of donors with 
iron depletion/deficiency, compared with 
4% of iron-replete donors. Female sex, 
younger age, and lower MCV and 
transferrin saturation values were 
significantly associated with pica. RLS 
was reported in 16% of subjects with iron 
depletion/deficiency compared with 11% 
of iron-replete donors. Iron replacement 
generally resulted in improvement of RLS 
symptoms, however, at least 4–6 weeks of 
iron therapy was necessary. Bryant et al, 
(42) found an important association of pica 
with finger sticks Hb of less 11.5 g/dL in 
female and less than 12.5 g/dL in male 
donors. 
Conclusion 
Early detection of iron deficiency among 
donors would allow suitable readjustment 
of donation intervals and would guide the 
use of iron supplementation. Screening 
donors’ serum ferritin levels at the time of 
first donation and then once every year is a 
very rational way to pick up an iron 
deficiency in a voluntary blood donor 
population. On the other hand, regular 
blood donation has several benefits, one of 
which is preventing enhance of body iron 
which can cause free radical formation in 
the body. Iron may also have deleterious 
effects on vascular function by increasing 
reactive oxygen species locally, decreasing 
the bioavailability of nitric oxide, 
impairing vasorelaxation, and promoting 
platelet adhesion and aggregation (43). In 
vitro studies have shown that iron acutely 
promotes platelet reactivity (44) and an 
increased risk of myocardial infarction 
(45).  
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